This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Michael A. Kass, MD

Arch Ophthalmol. 1985;103(4):504.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Poor compliance is an important limiting factor in the medical management of many chronic diseases. Yet, we have little information about defaulting from treatment regimens in ophthalmology. In part, this reflects methodologic problems of measuring compliance with topical ophthalmic medication. The recent development of eyedrop medication monitors allows us, for the first time, to make accurate and objective measurements of defaulting in ophthalmology.^1-3 The initial studies have been restricted to pilocarpine and indicate a high rate of defaulting in terms of missed doses and inadequate time spacing of doses.^4,5

See also p 529.

Good compliance is not an end in itself. The clinician must relate compliance to disease prognosis, especially if he or she is considering vigorous interventions to reduce defaulting. In an article published in this issue of the ARCHIVES, Granström⁶ finds little relationship between compliance with 4% pilocarpine treatment prescribed three times daily and progression . . . [Full Text PDF of this Article]

Author Affiliations
St Louis

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?